Description

The response of a patient with malignant lymphoma can be classified based on criteria that were presented at the 12th International Conference (2013) for Malignant Lymphoma in Lugano, Switzerland.


Patient selection: malignant lymphoma, Hodgkin's or non-Hodgkin's disease

 

A partial response may be classified based on:

(1) PET-CT based response, also known as the metabolic response

(2) CT based response, also referred to as the radiologic response

 

The PET-CT scan would not be relevant if the lymphoma did not show FDG-avidity.

 

Criteria for a partial PET-CT based response - all of the following:

(1) FDG uptake with score 4 or 5 on 5-PS at the end of treatment but reduced compared to baseline

(2) none or residual FDG uptake in bone marrow but reduced compared to baseline

(3) no new lesions

 

where:

FDG uptake before the end of treatment can be seen in responding tumor.

Diffuse uptake in the bone marrow may reflect reactive change to chemotherapy.

 

Criteria for a partial CT based response - all of the following:

(1) >= 50% decrease in the sum of the perpendicular products (SPD) in up to 6 measurable nodal and/or extranodal sites

(2) smaller lesions (not measured for SPD) are regressed or absent AND not increased

(3) if spleen was enlarged then length must have decreased > 50%

(4) no new lesions

 

where:

Assessment of bone marrow was designated not applicable to radiologic response.


To read more or access our algorithms and calculators, please log in or register.